Cognitive improvement after benzodiazepine discontinuation.
Salzman
C
C
D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D006801:Humans
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines